SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Kronos Bio, Inc. Buyout

Wilmington, Delaware--(Newsfile Corp. - May 1, 2025) - Rigrodsky Law, P.A. is investigating Kronos Bio, Inc. ("Kronos") (NASDAQ: KRON) regarding possible breaches of fiduciary duties and other violations of law related to Kronos' agreement to be acquired by Concentra Biosciences, LLC. Under the terms of the agreement, Kronos shareholders will receive $0.57 per share in cash.

To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-kronos-bio-inc.

To contact Seth D. Rigrodsky or Gina M. Serra cost free, call (302) 295-5310 or email [email protected].

Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/250546

You May Also Be Interested In

• Tenable Holdings, Inc. (TENB) to Join S&P SmallCap 600
• Simply Good Foods Company Securities Fraud Class Action Result of Undisclosed Acquisition Failures and Over 27% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
• PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti,